Combinatorial treatment of DNA and chromatin-modifying drugs cause cell death in human and canine osteosarcoma cell lines.
Downregulation of microRNAs (miRNAs) at the 14q32 locus stabilizes the expression of cMYC, thus significantly contributing to osteosarcoma (OS) pathobiology. Here, we show that downregulation of 14q32 miRNAs is epigenetically regulated. The predicted promoter regions of miRNA clusters at 14q32 locus...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2012-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC3434163?pdf=render |
| _version_ | 1811282217843818496 |
|---|---|
| author | Venugopal Thayanithy ChangWon Park Aaron L Sarver Reena V Kartha Derek M Korpela Ashley J Graef Clifford J Steer Jaime F Modiano Subbaya Subramanian |
| author_facet | Venugopal Thayanithy ChangWon Park Aaron L Sarver Reena V Kartha Derek M Korpela Ashley J Graef Clifford J Steer Jaime F Modiano Subbaya Subramanian |
| author_sort | Venugopal Thayanithy |
| collection | DOAJ |
| description | Downregulation of microRNAs (miRNAs) at the 14q32 locus stabilizes the expression of cMYC, thus significantly contributing to osteosarcoma (OS) pathobiology. Here, we show that downregulation of 14q32 miRNAs is epigenetically regulated. The predicted promoter regions of miRNA clusters at 14q32 locus showed no recurrent patterns of differential methylation, but Saos2 cells showed elevated histone deacetylase (HDAC) activity. Treatment with 4-phenylbutyrate increased acetylation of histones associated with 14q32 miRNAs, but interestingly, robust restoration of 14q32 miRNA expression, attenuation of cMYC expression, and induction of apoptosis required concomitant treatment with 5-Azacytidine, an inhibitor of DNA methylation. These events were associated with genome-wide gene expression changes including induction of pro-apoptotic genes and downregulation of cell cycle genes. Comparable effects were achieved in human and canine OS cells using the HDAC inhibitor suberoylanilide hydroxamic acid (SAHA/Vorinostat) and the DNA methylation inhibitor Zebularine (Zeb), with significantly more pronounced cytotoxicity in cells whose molecular phenotypes were indicative of aggressive biological behavior. These results suggested that the combination of these chromatin-modifying drugs may be a useful adjuvant in the treatment of rapidly progressive OS. |
| first_indexed | 2024-04-13T01:48:46Z |
| format | Article |
| id | doaj.art-b9d298e242d24dcda4d8522d88044f7f |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-13T01:48:46Z |
| publishDate | 2012-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-b9d298e242d24dcda4d8522d88044f7f2022-12-22T03:07:57ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0179e4372010.1371/journal.pone.0043720Combinatorial treatment of DNA and chromatin-modifying drugs cause cell death in human and canine osteosarcoma cell lines.Venugopal ThayanithyChangWon ParkAaron L SarverReena V KarthaDerek M KorpelaAshley J GraefClifford J SteerJaime F ModianoSubbaya SubramanianDownregulation of microRNAs (miRNAs) at the 14q32 locus stabilizes the expression of cMYC, thus significantly contributing to osteosarcoma (OS) pathobiology. Here, we show that downregulation of 14q32 miRNAs is epigenetically regulated. The predicted promoter regions of miRNA clusters at 14q32 locus showed no recurrent patterns of differential methylation, but Saos2 cells showed elevated histone deacetylase (HDAC) activity. Treatment with 4-phenylbutyrate increased acetylation of histones associated with 14q32 miRNAs, but interestingly, robust restoration of 14q32 miRNA expression, attenuation of cMYC expression, and induction of apoptosis required concomitant treatment with 5-Azacytidine, an inhibitor of DNA methylation. These events were associated with genome-wide gene expression changes including induction of pro-apoptotic genes and downregulation of cell cycle genes. Comparable effects were achieved in human and canine OS cells using the HDAC inhibitor suberoylanilide hydroxamic acid (SAHA/Vorinostat) and the DNA methylation inhibitor Zebularine (Zeb), with significantly more pronounced cytotoxicity in cells whose molecular phenotypes were indicative of aggressive biological behavior. These results suggested that the combination of these chromatin-modifying drugs may be a useful adjuvant in the treatment of rapidly progressive OS.http://europepmc.org/articles/PMC3434163?pdf=render |
| spellingShingle | Venugopal Thayanithy ChangWon Park Aaron L Sarver Reena V Kartha Derek M Korpela Ashley J Graef Clifford J Steer Jaime F Modiano Subbaya Subramanian Combinatorial treatment of DNA and chromatin-modifying drugs cause cell death in human and canine osteosarcoma cell lines. PLoS ONE |
| title | Combinatorial treatment of DNA and chromatin-modifying drugs cause cell death in human and canine osteosarcoma cell lines. |
| title_full | Combinatorial treatment of DNA and chromatin-modifying drugs cause cell death in human and canine osteosarcoma cell lines. |
| title_fullStr | Combinatorial treatment of DNA and chromatin-modifying drugs cause cell death in human and canine osteosarcoma cell lines. |
| title_full_unstemmed | Combinatorial treatment of DNA and chromatin-modifying drugs cause cell death in human and canine osteosarcoma cell lines. |
| title_short | Combinatorial treatment of DNA and chromatin-modifying drugs cause cell death in human and canine osteosarcoma cell lines. |
| title_sort | combinatorial treatment of dna and chromatin modifying drugs cause cell death in human and canine osteosarcoma cell lines |
| url | http://europepmc.org/articles/PMC3434163?pdf=render |
| work_keys_str_mv | AT venugopalthayanithy combinatorialtreatmentofdnaandchromatinmodifyingdrugscausecelldeathinhumanandcanineosteosarcomacelllines AT changwonpark combinatorialtreatmentofdnaandchromatinmodifyingdrugscausecelldeathinhumanandcanineosteosarcomacelllines AT aaronlsarver combinatorialtreatmentofdnaandchromatinmodifyingdrugscausecelldeathinhumanandcanineosteosarcomacelllines AT reenavkartha combinatorialtreatmentofdnaandchromatinmodifyingdrugscausecelldeathinhumanandcanineosteosarcomacelllines AT derekmkorpela combinatorialtreatmentofdnaandchromatinmodifyingdrugscausecelldeathinhumanandcanineosteosarcomacelllines AT ashleyjgraef combinatorialtreatmentofdnaandchromatinmodifyingdrugscausecelldeathinhumanandcanineosteosarcomacelllines AT cliffordjsteer combinatorialtreatmentofdnaandchromatinmodifyingdrugscausecelldeathinhumanandcanineosteosarcomacelllines AT jaimefmodiano combinatorialtreatmentofdnaandchromatinmodifyingdrugscausecelldeathinhumanandcanineosteosarcomacelllines AT subbayasubramanian combinatorialtreatmentofdnaandchromatinmodifyingdrugscausecelldeathinhumanandcanineosteosarcomacelllines |